Article Versions Notes

Tomida S, Goodenowe DB, Koyama T, Ozaki E, Kuriyama N, Morita M, Yamazaki Y, Sakaguchi K, Uehara R, Taguchi T. Plasmalogen Deficiency and Overactive Fatty Acid Elongation Biomarkers in Serum of Breast Cancer Patients Pre- and Post-Surgery—New Insights on Diagnosis, Risk Assessment, and Disease Mechanisms. Cancers. 2021; 13(16):4170. https://doi.org/10.3390/cancers13164170

Tomida, Satomi, Dayan B. Goodenowe, Teruhide Koyama, Etsuko Ozaki, Nagato Kuriyama, Midori Morita, Yasuyo Yamazaki, Koichi Sakaguchi, Ritei Uehara, and Tetsuya Taguchi. 2021. "Plasmalogen Deficiency and Overactive Fatty Acid Elongation Biomarkers in Serum of Breast Cancer Patients Pre- and Post-Surgery—New Insights on Diagnosis, Risk Assessment, and Disease Mechanisms" Cancers 13, no. 16: 4170. https://doi.org/10.3390/cancers13164170

Tomida, S., Goodenowe, D. B., Koyama, T., Ozaki, E., Kuriyama, N., Morita, M., Yamazaki, Y., Sakaguchi, K., Uehara, R., & Taguchi, T. (2021). Plasmalogen Deficiency and Overactive Fatty Acid Elongation Biomarkers in Serum of Breast Cancer Patients Pre- and Post-Surgery—New Insights on Diagnosis, Risk Assessment, and Disease Mechanisms. Cancers, 13(16), 4170. https://doi.org/10.3390/cancers13164170